Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial

Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T01:12:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Site revision updated to Revision: v3.4.2, replacing the previous Revision: v3.4.1 banner. The funding-status notice about government funding delays was removed, with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:13:43.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice was added at the top of the page informing users that information may not be up to date and directing to cc.nih.gov and opm.gov. Updated site revision to v3.4.1 and removed v3.4.0 reference.
    Difference
    0.3%
    Check dated 2026-02-04T10:18:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Introduced a glossary toggle and updated QC/versioning metadata (Last Update Submitted that Met QC Criteria and Revision: v3.4.0), while the older QC label and capitalization variants (Last Update Submitted that met QC Criteria; No FEAR Act data) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:08:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The revision label in the site footer was updated to v3.3.4, with no changes to study data or page functionality.
    Difference
    0.0%
    Check dated 2026-01-14T02:29:08.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing study sites (Alabama, Arkansas, Florida, Illinois, Maine, Maryland, South Carolina). Removed the older standalone location headers and the HHS Vulnerability Disclosure link.
    Difference
    0.7%
    Check dated 2025-12-23T17:25:37.000Z thumbnail image

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.